Molecular Oncology Diagnostics, An Issue of the Clinics in Laboratory Medicine. Clinics Review Articles: Laboratory Medicine Volume 42-3


Book
September 2022
Elsevier Health Science
ID: 5671497

In this issue of Clinics in Laboratory Medicine, guest editor Dr. Fei Dong brings his considerable expertise to the topic of Molecular Oncology Diagnostics. Top experts in the field review current practices in molecular oncology diagnostics, highlighting the rapid clinical adoption of next generation sequencing techniques. The articles address key laboratory considerations in the molecular testing of cancer specimens and the impact of advanced testing strategies on patient care.

Contains 15 practice-oriented topics including utility of single gene testing in cancer specimens; analytical principles of cancer next generation sequencing; principles and validation of bioinformatics pipelines for cancer next generation sequencing; panel sequencing for targeted therapy selection in solid tumors; and more.�
Provides in-depth clinical reviews on molecular oncology diagnostics, offering actionable insights for clinical practice.�
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.�

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Panel Sequencing for Targeted Therapy Selection in Solid TumorsMolecular Diagnostic Testing for Hematopoietic Neoplasms: Linking Pathogenic Drivers to Personalized DiagnosisSpecial Considerations in the Molecular Diagnostics of Pediatric NeoplasmsSpecimen Considerations in Molecular Oncology TestingUtility of Single-Gene Testing in Cancer SpecimensAnalytical Principles of Cancer Next Generation SequencingPrinciples and Validation of Bioinformatics Pipeline for Cancer Next-Generation SequencingBest Practice for Clinical Somatic Variant Interpretation and ReportingMolecular Detection of Oncogenic Gene RearrangementsCopy Number Analysis in Cancer Diagnostic TestingMolecular Biomarkers of Response to Cancer ImmunotherapyWhen Tissue Is the Issue: Expanding Cell-Free DNA "Liquid Biopsies� to Supernatants and Nonplasma BiofluidsGermline Testing for the Evaluation of Hereditary Cancer Predisposition

Authors

Fei Dong Associate Pathologist , Brigham and Women's Hospital , Assistant Professor , Harvard Medical School.

Table of Contents

Authors

Related Topics

Related Products

The Worldwide Market for Laboratory-Developed Tests (LDTs), 2023-2028

Laboratory Developed Tests Market Size, Share & Trends Analysis Report By Application, By Technology, By Regional Outlook and Forecast, 2024 - 2031

Global Clinical Medical Laboratory Services Market - Strategy & Trends with Forecasts by Assay Type, by Place, by Product, and by Country. Situation Analysis with Executive & Consultant Guides. 2024 to 2028

Clinical Laboratory Molecular Diagnostics for Infectious Disease Market: Forecasts by Application by Place and by Country, with Market Analysis & Executive Guides

Molecular Oncology Diagnostics Market by Product, Technology, Cancer Type, End User - Global Forecast 2025-2030